India’s drug regulation overdose

India’s ministry of health announced emergency plans recently to prevent irregularities in how the government approves new medicines. The sense of urgency comes after a 78-page parliamentary report that found that officials in India’s drug regulator, the Central Drugs Standard Control Organization (CDSCO), colluded with pharmaceutical firms to speed up medicine approvals. Such collusion is a problem, but the risk is that the government will waste energy tackling the wrong disease.

Read Full Story>>